{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "HKD", "exchange": "HKG", "shortName": "LEPU BIO-B", "longName": "Lepu Biopharma Co., Ltd.", "messageBoardId": "finmb_1686137449", "market": "hk_market", "marketState": "CLOSED", "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.46, "sharesOutstanding": 1605180032, "bookValue": 0.543, "fiftyDayAverage": 5.5628, "fiftyDayAverageChange": -0.01279974, "fiftyDayAverageChangePercent": -0.0023009528, "twoHundredDayAverage": 7.2937, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "regularMarketChangePercent": 5.513307, "regularMarketPrice": 5.55, "regularMarketChange": 0.28999996, "regularMarketTime": 1683878916, "regularMarketDayHigh": 5.68, "regularMarketDayRange": "5.3 - 5.68", "regularMarketDayLow": 5.3, "regularMarketVolume": 2542000, "regularMarketPreviousClose": 5.26, "bid": 5.47, "ask": 5.55, "fullExchangeName": "HKSE", "financialCurrency": "CNY", "regularMarketOpen": 5.3, "averageDailyVolume3Month": 1147978, "averageDailyVolume10Day": 824700, "fiftyTwoWeekLowChange": 0.6300001, "fiftyTwoWeekLowChangePercent": 0.1280488, "fiftyTwoWeekRange": "4.92 - 31.8", "fiftyTwoWeekHighChange": -26.25, "fiftyTwoWeekHighChangePercent": -0.8254717, "fiftyTwoWeekLow": 4.92, "fiftyTwoWeekHigh": 31.8, "twoHundredDayAverageChange": -1.7437, "twoHundredDayAverageChangePercent": -0.23906933, "marketCap": 8929783808, "priceToBook": 10.220995, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "ipoExpectedDate": "2022-02-15", "averageAnalystRating": "3.0 - Hold", "firstTradeDateMilliseconds": 1645579800000, "priceHint": 3, "symbol": "2157.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building 41", "address2": "2nd Floor Lane 518, Xinzhuan Road Songjiang District", "city": "Shanghai", "zip": "201612", "country": "China", "phone": "86 21 6769 6099", "website": "https://www.lepubiopharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on developing oncology therapeutics with a pipeline designed with a range of oncology products in China. The company develops oncology drug candidates, including antibody-drug conjugates (ADC), oncolytic virus drugs, and immunotherapies. It develops immuno-oncology products, such as HX008 Anti-PD-1 mAb and LP002 Anti-PD-L1 mAb; ADC products, including MRG003 EGFR-targeted ADC, MRG002 HER2-targeted ADC, MRG001 CD20-targeted ADC, MRG004A TF-targeted ADC, and CMG901 CLDNI8.2-targeted ADC; CG0070 oncolytic virus; and other drug candidates, such as HX008+OH2, LP002+OH2, and HX008+LP002. The company was incorporated in 2018 and is headquartered in Shanghai, China.", "fullTimeEmployees": 396, "companyOfficers": [{"maxAge": 1, "name": "Dr. Zhongjie  Pu", "age": 58, "title": "Exec. Chairman", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ziye  Sui M.D., Ph.D.", "age": 41, "title": "CEO & Director", "yearBorn": 1981, "fiscalYear": 2022, "totalPay": {"raw": 395643, "fmt": "395.64k", "longFmt": "395,643"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Chaohong  Hu", "age": 55, "title": "Co-CEO & Director", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 467788, "fmt": "467.79k", "longFmt": "467,788"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yunyi  Li", "age": 41, "title": "CFO & Board Sec.", "yearBorn": 1981, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Minmin  Qin Ph.D.", "age": 64, "title": "CTO & Sr. VP", "yearBorn": 1958, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Siu Kuen  Lai FCIS, FCS", "age": 46, "title": "Joint Company Sec.", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}